Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke
Jerzy Krupinski1, Marta M Turu, Mark Slevin
1Department of Neurology, Stroke Unit, Hospital Universitari de Bellvitge, Feixa Llarga s/n 08907 L'Hospitalet de Llobregat, Barcelona, Spain. krupinski@csub.scs.es
Insights
C-reactive protein (CRP) may predict stroke risk and severity. Higher CRP levels correlate with larger brain infarcts and poorer outcomes, but its exact role in stroke and the benefit of reducing CRP require further investigation.
Area of Science:
- Neurology
- Cardiovascular Research
- Inflammation Biology
Background:
- C-reactive protein (CRP) is a key inflammatory marker.
- Elevated CRP levels are associated with increased stroke risk and poorer neurological outcomes.
- The precise role of CRP in atherothrombosis and cerebrovascular disease is debated.
Purpose of the Study:
- To examine the predictive value of C-reactive protein (CRP) for stroke risk.
- To investigate the association between CRP concentrations and stroke severity, including infarct size and neurological outcome.
- To clarify the contribution of CRP to atherothrombosis versus its role as an acute-phase reactant in stroke.
Main Methods:
- Observational studies analyzing CRP levels in patients.
- Correlation analysis between CRP concentrations and clinical stroke parameters.
- Review of existing literature on CRP's role in cerebrovascular disease.
Main Results:
- Higher CRP concentrations are consistently linked to larger brain infarcts.
- Elevated CRP levels correlate with worse neurological outcomes post-stroke.
- The exact degree of stroke risk conferred by elevated CRP remains controversial.
Conclusions:
- CRP is a potential predictor of stroke risk and severity.
- Further research is necessary to elucidate CRP's exact role in stroke pathogenesis.
- Clinical utility of CRP reduction in stroke management requires additional studies.
Abstract:
C-reactive protein (CRP), an inflammatory marker, has been identified as a likely predictor of the risk of a future stroke. In clinical settings, it has been consistently observed that higher concentrations of CRP are associated with larger brain infarcts and worst neurologic outcome. However, there is still controversy over the degree of risk conferred by elevated CRP concentrations. CRP, like many other hemostatic factors, is an acute-phase protein and, therefore, it is not always clear whether its association with cerebrovascular disease reflects its contribution to atherothrombosis, its acute-phase condition, or both. Whether a reduction of CRP levels could be beneficial to stroke patients remains to be clarified. More studies are needed before CRP becomes a routine part of the evaluation of stroke patients.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Peripheral Artery Disease I: Introduction
Stroke: Introduction and Types
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease III: Interprofessional Care

